Abnormal post-translational and extracellular processing of brevican in plaque-bearing mice over-expressing APPsw.

作者: Joanne M. Ajmo , Lauren A. Bailey , Matthew D. Howell , Lisa K. Cortez , Keith R. Pennypacker

DOI: 10.1111/J.1471-4159.2010.06647.X

关键词:

摘要: Aggregation of amyloid-β in the forebrain Alzheimer's disease subjects may disturb molecular organization extracellular microenvironment that modulates neural and synaptic plasticity. Proteoglycans are major components this environment. To test hypothesis amyloid-β, or another amyloid precursor protein dependent mechanism modifies accumulation and/or turnover proteoglycans, we examined whether expression processing brevican, an abundant extracellular, chondroitin sulfate-bearing proteoglycan, were altered brains amyloid-β-depositing transgenic mice (APPsw) as a model disease. The size sulfate chains attached to brevican was smaller hippocampal tissue from APPsw bearing deposits compared non-transgenic mice, likely due changes chains. Also, abundance proteolytic fragment markedly diminished extracts several telencephalic regions yet these immunoreactive fragments appeared accumulate adjacent plaque edge. These results suggest exert inhibitory effects on cleavage mechanisms responsible for synthesis proteoglycans. Since proteoglycans stabilize structure inhibit plasticity, defective observed amyloid-β-bearing potentially end-stage human disease, contribute deficient

参考文章(63)
P.L. McGeer, H. Akiyama, S. Itagaki, E.G. McGeer, Immune system response in Alzheimer's disease. Canadian Journal of Neurological Sciences. ,vol. 16, pp. 516- 527 ,(1989) , 10.1017/S0317167100029863
M Asahina, T Hattori, Y Yoshiyama, Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain. Clinical Neuropathology. ,vol. 20, pp. 60- 63 ,(2001)
H. Yamada, K. Watanabe, M. Shimonaka, Y. Yamaguchi, Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. Journal of Biological Chemistry. ,vol. 269, pp. 10119- 10126 ,(1994) , 10.1016/S0021-9258(17)36998-3
Charles, J. Malemud, Matrix metalloproteinases (MMPs) in health and disease: an overview Frontiers in Bioscience. ,vol. 11, pp. 1696- 1701 ,(2006) , 10.2741/1915
Carl, R. Flannery, MMPs and ADAMTSs: functional studies Frontiers in Bioscience. ,vol. 11, pp. 544- 569 ,(2006) , 10.2741/1818
Lennart Mucke, Eliezer Masliah, Gui-Qiu Yu, Margaret Mallory, Edward M. Rockenstein, Gwen Tatsuno, Kang Hu, Dora Kholodenko, Kelly Johnson-Wood, Lisa McConlogue, High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. The Journal of Neuroscience. ,vol. 20, pp. 4050- 4058 ,(2000) , 10.1523/JNEUROSCI.20-11-04050.2000
Dave Morgan, David M. Diamond, Paul E. Gottschall, Kenneth E. Ugen, Chad Dickey, John Hardy, Karen Duff, Paul Jantzen, Giovanni DiCarlo, Donna Wilcock, Karen Connor, Jaime Hatcher, Caroline Hope, Marcia Gordon, Gary W. Arendash, A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. ,vol. 408, pp. 982- 985 ,(2000) , 10.1038/35050116
Christine E. Bandtlow, Dieter R. Zimmermann, Proteoglycans in the Developing Brain: New Conceptual Insights for Old Proteins Physiological Reviews. ,vol. 80, pp. 1267- 1290 ,(2000) , 10.1152/PHYSREV.2000.80.4.1267
Norifumi Watanabe, Wataru Araki, De-Hua Chui, Takao Makifuchi, Yasuo Ihara, Takeshi Tabira, Glypican-1 as an Aβ binding HSPG in the human brain: Its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease The FASEB Journal. ,vol. 18, pp. 1013- 1015 ,(2004) , 10.1096/FJ.03-1040FJE
Nora John, Hans Krügel, Renato Frischknecht, Karl-Heinz Smalla, Christian Schultz, Michael R. Kreutz, Eckart D. Gundelfinger, Constanze I. Seidenbecher, Brevican-containing perineuronal nets of extracellular matrix in dissociated hippocampal primary cultures. Molecular and Cellular Neuroscience. ,vol. 31, pp. 774- 784 ,(2006) , 10.1016/J.MCN.2006.01.011